Month: July 2025

In a video interview with Pharma Commerce, Sean O’Hearen, founder and principal consultant at 1st Line Partners, discusses the critical issue of substandard and falsified (SF) medicines and the lack of awareness among healthcare professionals (HCPs). Despite SF drugs posing a growing global health risk, only 2% of HCPs are trained to detect them, and […]

In a video interview with Pharma Commerce, Murray Aitken, executive director of the IQVIA Institute for Human Data Science, explains the extensive process behind developing the “Global Use of Medicines Outlook Through 2029” report. The creation of this comprehensive resource spans several months and integrates proprietary IQVIA datasets, including the MIDAS (Market Intelligence Data Analytics […]

Chandler’s pharmaceutical experience spans years in the pharma services space, powered by strategic leadership roles. Image Credit: Knipper Health Following Frazier Healthcare Partners’ investment in Knipper Health, Willis Chandler has officially been appointed as Knipper’s president and CEO.1 How exactly does Knipper aim to get patients started on treatment at a faster rate? The therapy […]

In a video interview with Pharma Commerce, Murray Aitken, executive director of the IQVIA Institute for Human Data Science, explains the extensive process behind developing the “Global Use of Medicines Outlook Through 2029” report. The creation of this comprehensive resource spans several months and integrates proprietary IQVIA datasets, including the MIDAS (Market Intelligence Data Analytics […]

Gilead plans to supply enough doses to assist up to two million individuals over three years in nations supported by the Global Fund. Image Credit: Adobe Stock Images/TobiasArhelger.com Gilead Sciences is collaborating with the Global Fund to Fight AIDS, Tuberculosis and Malaria (Global Fund) to provide lenacapavir for the prevention of HIV as pre-exposure prophylaxis […]

Few times in the evolution of a pharmaceutical company are as exciting as during the flurry of launch readiness activities focused on bringing a new drug to market. From the new drug application (NDA) submission to the Prescription Drug User Fee Act (PDUFA) date, the brand team is fully engaged—selecting a product name, developing marketing […]

Removing Financial Barriers to Boost Trial Diversity In an interview with Applied Clinical Trials, Heather Horville, solutions consultant, Greenphire, emphasized the importance of removing financial and logistical barriers—such as through reimbursements, stipends, and prepaid travel—to improve clinical trial diversity and retention, stressing the need for early planning, site-level coordination, and patient-centered support. How Prescribing Power […]

Despite these medications being both available and affordable, racial, ethnic, and socioeconomic disparities came to light when it came to accessing COVID-19 treatment. Image Credit: Adobe Stock Images/Steheap.com As history has shown, being able to act fast when it comes to outpatient treatment for a COVID-19 infection provide a high success rate for decreasing the […]

In a video interview with Pharma Commerce, Marschall Runge, MD, PhD, dean of the University of Michigan Medical School and author of The Great Healthcare Disruption, addresses the potential impacts of a federal cap on Medicaid provider taxes and how such a policy could affect hospital systems. particularly in states like Michigan that have uniquely […]

In this Pharmaceutical Commerce roundtable discussion, Nicholas Saraceno, editor of Pharmaceutical Commerce and the peer exchange’s moderator, introduced a discussion on the pharmaceutical supply chain, highlighting its complexity and importance in delivering medications safely and efficiently from manufacturers to patients. The conversation explored the roles of various stakeholders, the need for supply chain resilience and quality control, […]

PC: In the absence of public participation at the federal level, how can industry leaders collaborate with advocacy groups to sustain meaningful engagement with regulators? Leuchter: Experienced regulators are very attuned to how patients and caregivers live day to day with a given disease. That understanding is a key part of how they evaluate opportunities […]

In a video interview with Pharma Commerce, Marschall Runge, MD, PhD, dean of the University of Michigan Medical School and author of The Great Healthcare Disruption, addresses the potential impacts of a federal cap on Medicaid provider taxes and how such a policy could affect hospital systems. particularly in states like Michigan that have uniquely […]

President Trump noted that import taxes on pharmaceuticals of up to 200% could come forthcoming. Image Credit: Adobe Stock Images/MohammadXte.com The pharmaceutical industry has been anxiously standing by, waiting on the possibility that tariffs on imports entering the United States could take effect, just not at this potential level. There had been talks over the […]

In a video interview with Pharma Commerce, Marschall Runge, MD, PhD, dean of the University of Michigan Medical School and author of The Great Healthcare Disruption, addresses the potential impacts of a federal cap on Medicaid provider taxes and how such a policy could affect hospital systems. particularly in states like Michigan that have uniquely […]

All of the levies come with a stipulation—if these nations increase their tariffs, the United States will raise them on its end as well. Image Credit: Adobe Stock Images/Zenday.com Yesterday, per AP and CBS News,1,2 US President Donald Trump enacted a multitude of tariffs expected to go into effect on Aug. 1, including a 25% […]

PC: How might this change affect payer negotiations and reimbursement decisions, particularly for innovative or high-cost therapies? Leuchter: When it comes to rare diseases, patients often suffer from a wide range of symptoms—some of which receive more attention from drug developers than others. That’s often because targeting specific symptoms can be a higher-probability path to […]